ATE217875T1 - Acylphosph(on)at beta-lactamase inhibitoren - Google Patents

Acylphosph(on)at beta-lactamase inhibitoren

Info

Publication number
ATE217875T1
ATE217875T1 AT98965488T AT98965488T ATE217875T1 AT E217875 T1 ATE217875 T1 AT E217875T1 AT 98965488 T AT98965488 T AT 98965488T AT 98965488 T AT98965488 T AT 98965488T AT E217875 T1 ATE217875 T1 AT E217875T1
Authority
AT
Austria
Prior art keywords
beta
lactamase inhibitors
inhibitors
acylphosph
ate
Prior art date
Application number
AT98965488T
Other languages
English (en)
Inventor
Jeffrey M Besterman
Jubrail Rahil
Rex Pratt
Original Assignee
Methylgene Inc
Wesleyan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Methylgene Inc, Wesleyan University filed Critical Methylgene Inc
Application granted granted Critical
Publication of ATE217875T1 publication Critical patent/ATE217875T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/409Compounds containing the structure P(=X)-X-acyl, P(=X) -X-heteroatom, P(=X)-X-CN (X = O, S, Se)
    • C07F9/4093Compounds containing the structure P(=X)-X-C(=X)- (X = O, S, Se)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/095Compounds containing the structure P(=O)-O-acyl, P(=O)-O-heteroatom, P(=O)-O-CN
    • C07F9/096Compounds containing the structure P(=O)-O-C(=X)- (X = O, S, Se)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/098Esters of polyphosphoric acids or anhydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65744Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98965488T 1997-12-24 1998-12-23 Acylphosph(on)at beta-lactamase inhibitoren ATE217875T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6883797P 1997-12-24 1997-12-24
PCT/US1998/027518 WO1999033850A1 (en) 1997-12-24 1998-12-23 NOVEL β-LACTAMASE AND DD-PEPTIDASE INHIBITORS

Publications (1)

Publication Number Publication Date
ATE217875T1 true ATE217875T1 (de) 2002-06-15

Family

ID=22085029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98965488T ATE217875T1 (de) 1997-12-24 1998-12-23 Acylphosph(on)at beta-lactamase inhibitoren

Country Status (10)

Country Link
US (1) US6608046B1 (de)
EP (1) EP1042334B1 (de)
JP (1) JP2002503643A (de)
KR (1) KR100591572B1 (de)
AT (1) ATE217875T1 (de)
AU (1) AU755799B2 (de)
CA (1) CA2315821A1 (de)
DE (1) DE69805548T2 (de)
ES (1) ES2178302T3 (de)
WO (1) WO1999033850A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599889B2 (en) * 1997-12-24 2003-07-29 Methylgere, Inc. Acyl phosphonate inhibitors of β-lactamases
KR100686988B1 (ko) 1999-07-06 2007-02-27 메틸진, 인크. β-락타마제의 술폰아미도메틸 포스포네이트 저해제
US6884791B2 (en) 1999-07-06 2005-04-26 Methylgene, Inc. Inhibitors of β-lactamase
US6921756B2 (en) 1999-07-06 2005-07-26 Methylgene, Inc. Inhibitors of β-lactamase
AU2007332968B2 (en) * 2006-05-22 2013-07-11 Methylgene Inc. Novel inhibitors of beta-lactamase
AU2007268081A1 (en) * 2006-05-22 2007-12-06 Methylgene Inc. Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase
WO2009114921A1 (en) * 2008-03-17 2009-09-24 Dmitrienko Gary I INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES
CA2851984C (en) * 2011-10-14 2020-10-27 Universite De Liege Method for measuring beta-lactam antibiotics
JP2015506360A (ja) * 2012-01-06 2015-03-02 ユニバーシティ・オブ・サウス・フロリダ 組成物、使用方法および処置方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
JP3021041B2 (ja) * 1990-03-14 2000-03-15 ザ ユニバーシティ オブ トロント イノベーションズ ファンデーション アシルリン酸エステルおよびそれによる蛋白質の改質
US5250665A (en) * 1991-05-31 1993-10-05 The University Of Toronto Innovations Foundation Specifically β-β cross-linked hemoglobins and method of preparation

Also Published As

Publication number Publication date
DE69805548D1 (en) 2002-06-27
WO1999033850A8 (en) 1999-09-10
KR100591572B1 (ko) 2006-06-20
EP1042334B1 (de) 2002-05-22
JP2002503643A (ja) 2002-02-05
AU2094599A (en) 1999-07-19
US6608046B1 (en) 2003-08-19
ES2178302T3 (es) 2002-12-16
EP1042334A1 (de) 2000-10-11
KR20010033621A (ko) 2001-04-25
AU755799B2 (en) 2002-12-19
CA2315821A1 (en) 1999-07-08
DE69805548T2 (de) 2003-01-09
WO1999033850A1 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
DE59202238D1 (de) Hilfsmittel für laparoskopische Operationen.
NO20006323L (no) Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse
PT1193270E (pt) Pirrolobenzodiazepinas
AU2056197A (en) M-amidino phenyl analogs as factor xa inhibitors
ES2149883T3 (es) Sintesis quimica de taxol y de derivados de taxol.
EA199700155A1 (ru) Ингибиторы тромбина
ATE233274T1 (de) Oxyiminopregnancarbolactone
TR199800773T2 (xx) Trombin inhibit�rleri.
EP0932606A4 (de) Prenyl-transferase inhibitoren
IT1285770B1 (it) Composti corticoidei
PT989972E (pt) Composicoes farmaceuticas com prostaglandinas
ATE217875T1 (de) Acylphosph(on)at beta-lactamase inhibitoren
NO934628L (no) Retrovirus-protease-inhibitorer
ATE311397T1 (de) Sulfonamidomethyl phosphonat beta-lactamase inhibitoren
TR199800182T1 (xx) 2-oksazolidinon t�revlerinin bir kapta sentezi.
ATE213944T1 (de) Verwendung von immunomodulatoren
NO981393D0 (no) Guanidinoproteasehemmere
MX9801190A (es) Inhibidores de prolil endopeptidasa.
GB2324091B (en) Metalloproteinase inhibitors
YU83100A (sh) Fkbp inhibitori
TR199701298T1 (xx) Tetralinler.
DE69625910D1 (de) Penamsulfone als beta-laktamase inhibitoren
ZA966885B (en) Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
HUP9901101A2 (hu) Stabil peroxigénes fehérítőt tartalmazó készítmények